Researchers may have cured female HIV for the first time

Rate this post
Researchers May Treat Female HIV for the First Time: Report

The human immunodeficiency virus (HIV) affects many people around the world and causes the deadly disease of AIDS. Scientists have long sought that permanent cure, and they seem to have finally made great strides in their research. According to a recent report, a team of American researchers may have cured a woman’s HIV time for the first time.

Researchers may have cured female HIV for the first time

According to the report by NBC News, A group of researchers in the United States may have treated female HIV for the first time in human history. Researchers used their experience to analyze and come up with past successes and failures. New state-of-the-art stem cell transplantation method It uses specialized stem cells with rare genetic abnormalities that give natural resistance to the cells targeted by the immunodeficiency virus. They believe that this treatment can be expanded to a pool of at least 12 people annually.

Only two patients have been able to treat HIV-infected patients in the past. However, in both previous cases, the patient was male. In this case, the researchers were able to succeed for the first time using the female stem transplant method. Only the third patient will be cured of HIV.

However, treatment has some fatal side effects, and researchers say it does not apply to some or all HIV-infected patients worldwide. The Stem cell transplantation actually replaces your immune system with someone else’s immune system, Make it a dangerous process. This causes certain types of cancer in patients with high case fatality.

Some experts call this unethical because treatment can be a toxic and deadly procedure for the patient.Dr. Deborah Persaud, a pediatric infectious disease specialist at John Hopkins University School of Medicine, praised new cases of potential HIV treatment and stem transplantation “Except for the millions of people who live with HIV, it’s not yet a viable strategy.”

Nonetheless, Karl Diffenbach, director of the AIDS division at the National Institute of Infectious Diseases, states the success story of such HIV treatment: We will continue to provide hope. “It is important to continue to succeed in line with this policy.” Added Diefenbach.